Optimizing human Treg immunotherapy by Treg subset selection and E-selectin ligand expression.
Optimizing human Treg immunotherapy by Treg subset selection and E-selectin ligand expression.
复制标题
DOI:
10.1038/s41598-017-17981-z
复制
发表时间:
2018-01-11
影响因子:
4.6
通讯作者:
Baecher-Allan C
中科院分区:
文献类型:
--
作者:
Donnelly C;Dykstra B;Mondal N;Huang J;Kaskow BJ;Griffin R;Sackstein R;Baecher-Allan C
While human Tregs hold immense promise for immunotherapy, their biologic variability poses challenges for clinical use. Here, we examined clinically-relevant activities of defined subsets of freshly-isolated and culture-expanded human PBMC-derived Tregs. Unlike highly suppressive but plastic memory Tregs (memTreg), naïve Tregs (nvTreg) exhibited the greatest proliferation, suppressive capacity after stimulation, and Treg lineage fidelity. Yet, unlike memTregs, nvTregs lack Fucosyltransferase VII and display low sLeX expression, with concomitant poor homing capacity. In vitro nvTreg expansion augmented their suppressive function, but did not alter the nvTreg sLeX-l ° w glycome. However, exofucosylation of the nvTreg surface yielded high sLeX expression, promoting endothelial adhesion and enhanced inhibition of xenogeneic aGVHD. These data indicate that the immature Treg glycome is under unique regulation and that adult PBMCs can be an ideal source of autologous-derived therapeutic Tregs, provided that subset selection and glycan engineering are engaged to optimize both their immunomodulation and tropism for inflammatory sites.
登录
查看更多内容
DOI:
10.1084/jem.20060772
发表时间:
2006-07-10
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
通讯作者:
--
影响因子:
15.3
作者:
Tu, L;Delahunty, M D;Ding, H;Luscinskas, F W;Tedder, T F
通讯作者:
Tedder, T F
影响因子:
4.4
作者:
Baecher-Allan, Clare;Wolf, Elizabeth;Haller, David A.
通讯作者:
Haller, David A.
影响因子:
2.2
作者:
Kummitha, China Malakondaiah;Shirure, Venktesh S.;Goetz, Douglas J.
通讯作者:
Goetz, Douglas J.
影响因子:
4.4
作者:
Antons, Amanda K.;Wang, Rui;Unutmaz, Derya
通讯作者:
Unutmaz, Derya